NCT02345057View on ClinicalTrials.gov

A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Type 2 Diabetic Subjects With Microalbuminuria

PHASE2CompletedINTERVENTIONAL

Enrollment

365

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

July 31, 2016

Conditions

Diabetic Nephropathy

Interventions

DRUG

CS-3150

DRUG

placebo

Trial Locations (1)

862-0976

Kumamoto

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Daiichi Sankyo

INDUSTRY